PGD2 levels were found to increase, to activate basophils, and to control both total IgE and autoreactive IgG levels in SLE, which is an autoimmune disease with a high prevalence of autoreactive IgE [71,108]. This evidence concerns the gene IGHE and systemic lupus erythematosus.